Advancements in Treatment Modalities and Rising Diabetes Prevalence Drive Market Growth The diabetic gastroparesis treatment market size is on a trajectory of significant growth, with projections indicating an increase from USD 4.68 billion in 2022 to approximately USD 6.41 billion by 2029, reflecting a compound annual growth rate (CAGR) of 4.6%. This expansion is primarily attributed...